The nonobese diabetic (NOD) mouse spontaneously develops an autoimmune diabetes that shares many immunogenetic features with human insulin-dependent diabetes mellitus (IDDM), type 1 diabetes. The mononuclear cell infiltrates in the islet, which results in the development of insulitis (a prerequisite
Abnormalities of dendritic cell precursors in the pancreas of the NOD mouse model of diabetes
β Scribed by Jojanneke M. C. Welzen-Coppens; Cornelia G. van Helden-Meeuwsen; Hemmo A. Drexhage; Marjan A. Versnel
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 421 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The nonβobese diabetic (NOD) mouse is a widely used animal model for the study of human diabetes. Before the start of lymphocytic insulitis, DC accumulation around islets of Langerhans is a hallmark for autoimmune diabetes development in this model. Previous experiments indicated that an inflammatory influx of these DCs in the pancreas is less plausible. Here, we investigated whether the pancreas contains DC precursors and whether these precursors contribute to DC accumulation in the NOD pancreas. Fetal pancreases of NOD and control mice were isolated followed by FACS using ERβMP58, Ly6G, CD11b and Ly6C. Sorted fetal pancreatic ERβMP58^+^ cells were cultured with GMβCSF and tested for DC markers and antigen processing. CFSE labeling and Kiβ67 staining were used to determine cell proliferation in cultures and tissues. Ly6C^hi^ and Ly6C^low^ precursors were present in fetal pancreases of NOD and control mice. These precursors developed into CD11c^+^MHCII^+^CD86^+^ DCs capable of processing DQβOVA. ERβMP58^+^ cells in the embryonic and preβdiabetic NOD pancreas had a higher proliferation capacity. Our observations support a novel concept that preβdiabetic DC accumulation in the NOD pancreas is due to aberrant enhanced proliferation of local precursors, rather than to aberrant βinflammatory infiltrationβ from the circulation.
π SIMILAR VOLUMES
The development of diabetes in non-obese diabetic (NOD) mice, which normally takes between 3 and 7 months, can be accelerated by cyclophosphamide (CY) injections, with rapid progression to diabetes within only 2Β±3 weeks. This insulin-dependent diabetes mellitus (IDDM) can be prevented or delayed in